Two Years Research Project Into RNAi Mediated Regulatory Networks

[Guest guest]

Two Years Research Project Into RNAi Mediated Regulatory Networks

http://www.medicalnewstoday.com/medicalnews.php?newsid=51963

Genomatix Software GmbH of Munich, Germany, has won a " BioChance "

research contract from the German Federal Ministry of Education and

Research to pursue research in RNAi mediated regulatory networks and

to further expand its competence and product line into this exciting

new field. The project is scheduled to run for two years and is worth

more than US$ 1.6 million.

Genomatix own unique competence in the biology of gene regulation

will be complemented by at least two academic research partners (the

LMU Munich and the DKFZ Heidelberg) who will carry out the wet lab

experimental part of the research.

This project represents another milestone in the development of

complete solutions for which Genomatix is known for. " Regulatory RNAs

represent a very important but yet underestimated part of gene

regulation. As Genomatix is especially emphasizing the network

aspects, this project will directly enhance many parts of the

Genomatix portfolio of solutions. For example, Genomatix already

provides the most complete solution for microarray analysis, which

will immediately benefit from the results of this project. " , says Dr.

Werner, CEO & CSO of Genomatix.

" The unique data and capabilities of our ElDorado genome annotation

system and mapping pipeline provide a significant boost to the

project from the very beginning " adds Dr. Matthias Scherf, head of

Genomatix' Discovery Group and project leader on the microRNA project.